BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 17415764)

  • 1. Toll-like receptors in the interface membrane around loosening total hip replacement implants.
    Takagi M; Tamaki Y; Hasegawa H; Takakubo Y; Konttinen L; Tiainen VM; Lappalainen R; Konttinen YT; Salo J
    J Biomed Mater Res A; 2007 Jun; 81(4):1017-26. PubMed ID: 17415764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased expression of toll-like receptors in aseptic loose periprosthetic tissues and septic synovial membranes around total hip implants.
    Tamaki Y; Takakubo Y; Goto K; Hirayama T; Sasaki K; Konttinen YT; Goodman SB; Takagi M
    J Rheumatol; 2009 Mar; 36(3):598-608. PubMed ID: 19208601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles.
    Hirayama T; Tamaki Y; Takakubo Y; Iwazaki K; Sasaki K; Ogino T; Goodman SB; Konttinen YT; Takagi M
    J Orthop Res; 2011 Jul; 29(7):984-92. PubMed ID: 21308757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Toll-like receptors and aseptic loosening of hip endoprosthesis-a potential to respond against danger signals?
    Lähdeoja T; Pajarinen J; Kouri VP; Sillat T; Salo J; Konttinen YT
    J Orthop Res; 2010 Feb; 28(2):184-90. PubMed ID: 19725103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Profile of toll-like receptor-positive cells in septic and aseptic loosening of total hip arthroplasty implants.
    Pajarinen J; Cenni E; Savarino L; Gomez-Barrena E; Tamaki Y; Takagi M; Salo J; Konttinen YT
    J Biomed Mater Res A; 2010 Jul; 94(1):84-92. PubMed ID: 20127718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Over-expression of p53/BAK in aseptic loosening after total hip replacement.
    Landgraeber S; Toetsch M; Wedemeyer C; Saxler G; Tsokos M; von Knoch F; Neuhäuser M; Löer F; von Knoch M
    Biomaterials; 2006 May; 27(15):3010-20. PubMed ID: 16445975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor alpha blockade treatment down-modulates the increased systemic and local expression of Toll-like receptor 2 and Toll-like receptor 4 in spondylarthropathy.
    De Rycke L; Vandooren B; Kruithof E; De Keyser F; Veys EM; Baeten D
    Arthritis Rheum; 2005 Jul; 52(7):2146-58. PubMed ID: 15986373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of toll-like receptors 3 and 4 in synovial tissue from patients with early rheumatoid arthritis: toll-like receptor expression in early and longstanding arthritis.
    Ospelt C; Brentano F; Rengel Y; Stanczyk J; Kolling C; Tak PP; Gay RE; Gay S; Kyburz D
    Arthritis Rheum; 2008 Dec; 58(12):3684-92. PubMed ID: 19035519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of ADAM9 (meltrin-gamma) around aseptically loosened total hip replacement implants.
    Ma GF; Liljeström M; Ainola M; Chen T; Tiainen VM; Lappalainen R; Konttinen YT; Salo J
    Rheumatology (Oxford); 2006 Jul; 45(7):808-14. PubMed ID: 16418197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ectopic expression of macrophage scavenger receptor MARCO in synovial membrane-like interface tissue in aseptic loosening of total hip replacement implants.
    Zhao DS; Ma GF; Selenius M; Salo J; Pikkarainen T; Konttinen YT
    J Biomed Mater Res A; 2010 Feb; 92(2):641-9. PubMed ID: 19235220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BAFF synthesis by rheumatoid synoviocytes is positively controlled by alpha5beta1 integrin stimulation and is negatively regulated by tumor necrosis factor alpha and Toll-like receptor ligands.
    Alsaleh G; Messer L; Semaan N; Boulanger N; Gottenberg JE; Sibilia J; Wachsmann D
    Arthritis Rheum; 2007 Oct; 56(10):3202-14. PubMed ID: 17907168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toll-like receptors and chondrocytes: the lipopolysaccharide-induced decrease in cartilage matrix synthesis is dependent on the presence of toll-like receptor 4 and antagonized by bone morphogenetic protein 7.
    Bobacz K; Sunk IG; Hofstaetter JG; Amoyo L; Toma CD; Akira S; Weichhart T; Saemann M; Smolen JS
    Arthritis Rheum; 2007 Jun; 56(6):1880-93. PubMed ID: 17530716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of a novel osteoclast-stimulating factor, ADAM8, in interface tissue around loosened hip prostheses.
    Mandelin J; Li TF; Hukkanen MV; Liljeström M; Chen ZK; Santavirta S; Kitti U; Konttinen YT
    J Rheumatol; 2003 Sep; 30(9):2033-8. PubMed ID: 12966612
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative expression of Toll-like receptor-2, -4, and -9 in dendritic cells generated from blasts of patients with acute myeloid leukemia.
    Schmitt A; Li L; Giannopoulos K; Greiner J; Reinhardt P; Wiesneth M; Schmitt M
    Transfusion; 2008 May; 48(5):861-70. PubMed ID: 18208411
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process.
    Papadimitraki ED; Choulaki C; Koutala E; Bertsias G; Tsatsanis C; Gergianaki I; Raptopoulou A; Kritikos HD; Mamalaki C; Sidiropoulos P; Boumpas DT
    Arthritis Rheum; 2006 Nov; 54(11):3601-11. PubMed ID: 17075805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High macrophage-colony stimulating factor levels in synovial fluid of loose artificial hip joints.
    Takei I; Takagi M; Ida H; Ogino T; Santavirta S; Konttinen YT
    J Rheumatol; 2000 Apr; 27(4):894-9. PubMed ID: 10782812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein expression of MMP-13, uPA, and PAI-1 in pseudocapsular and interface tissue around implants of loose artificial hip joints and in osteoarthritis.
    Diehl P; Hantke B; Hennig M; Tschesche H; Mittelmeier W; Schmitt M; Muehlenweg B
    Int J Mol Med; 2004 May; 13(5):711-5. PubMed ID: 15067375
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Toll-like receptors in healthy and allergic conjunctiva.
    Bonini S; Micera A; Iovieno A; Lambiase A; Bonini S
    Ophthalmology; 2005 Sep; 112(9):1528; discussion 1548-9. PubMed ID: 16023216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta 1 and 2 in the synovial-like interface membrane between implant and bone in loosening of total hip arthroplasty.
    Konttinen YT; Waris V; Xu JW; Jiranek WA; Sorsa T; Virtanen I; Santavirta S
    J Rheumatol; 1997 Apr; 24(4):694-701. PubMed ID: 9101504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ERCC1 expression in aseptic loosening after total hip replacement.
    Landgraeber S; von Knoch M; Löer F; Wegner A; Tsokos M; Schmid KW; Totsch M
    J Biomed Mater Res A; 2010 Feb; 92(2):556-62. PubMed ID: 19235214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.